{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-1975-N-0336\" and posted_year = 2011 sorted by posted_date descending", "rows": [["FDA-1975-N-0336-0031", "FDA", "FDA-1975-N-0336", "Request for Hearing with Supporting Information Regarding Proposed Withdrawal of Approved Applications for Anticholinergic and Barbiturate Combination Drug Products - Supplemental Information (Vol. 141-B)", "Other", "Request for Hearing", "2011-09-13T04:00:00Z", 2011, 9, "2011-09-13T04:00:00Z", null, "2017-12-05T21:44:07Z", null, 0, 0, "0900006480ee57db"], ["FDA-1975-N-0336-0027", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Premo Pharmaceutical Labs, Inc.,  - [Sheppard Mulln Richter & Hampton LLP]  DESI 10837 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-07T22:36:20Z", null, 1, 0, "0900006480f08fee"], ["FDA-1975-N-0336-0015", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Poythress Laboratories, Inc., DESI 597 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2011-08-30T19:38:48Z", null, 0, 0, "0900006480f08da7"], ["FDA-1975-N-0336-0030", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Cord Labs, Inc., - [Arent Fox LLP]  DESI 10837 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2011-08-30T19:49:09Z", null, 0, 0, "0900006480f08ff6"], ["FDA-1975-N-0336-0024", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Beecham Laboratories, DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2011-08-30T19:46:03Z", null, 0, 0, "0900006480f08fb3"], ["FDA-1975-N-0336-0026", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Premo Pharmaceutical. - [Teva Pharmaceuticals]  DESI 10837 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-12T05:03:05Z", null, 1, 0, "0900006480f08fb7"], ["FDA-1975-N-0336-0017", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to  Reid-Provident Laboratories, Inc.'s., DESI 597  [ Abbott Laboratories] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-07T22:36:37Z", null, 1, 0, "0900006480f08ede"], ["FDA-1975-N-0336-0019", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-07T22:36:31Z", null, 1, 0, "0900006480f08ee2"], ["FDA-1975-N-0336-0023", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to B.F. Ascher & Co., Inc., DESI 597 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-12T05:03:05Z", null, 1, 0, "0900006480f08f95"], ["FDA-1975-N-0336-0025", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to  Richlyn Laboratories, Inc.., - [Impax Laboratories, Inc.]  DESI 597 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-12T05:03:05Z", null, 1, 0, "0900006480f08fb5"], ["FDA-1975-N-0336-0021", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to West-Ward Pharmaceutical Corp., DESI 597 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2013-01-08T03:27:35Z", null, 0, 0, "0900006480f08f91"], ["FDA-1975-N-0336-0014", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to National  Pharmaceuticals Manufacturing Co.,, DESI 597 - [ Actavis US] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-07T22:36:30Z", null, 1, 0, "0900006480f08da5"], ["FDA-1975-N-0336-0016", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Purepac Pharmaceutical's - [ Actavis ] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2011-08-30T19:39:08Z", null, 0, 0, "0900006480f08edc"], ["FDA-1975-N-0336-0022", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to William Rorer, Inc., DESI 597 [ Sanofi-aventis U,S.] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-12T05:03:04Z", null, 1, 0, "0900006480f08f93"], ["FDA-1975-N-0336-0020", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Stuart Pharmaceuticals, DESI 597 - [ AstraZeneca Pharmaceuticals LP] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2011-08-30T19:42:14Z", null, 0, 0, "0900006480f08f8d"], ["FDA-1975-N-0336-0028", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Roche pharmaceutical, - [Genentech, Inc.] - DESI 10837 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2011-08-30T19:48:23Z", null, 0, 0, "0900006480f08ff0"], ["FDA-1975-N-0336-0029", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Roche Laboratories, - [Valeant Pharmaceuticals International, Inc] - DESI 10837 - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-07T22:36:38Z", null, 1, 0, "0900006480f08ff4"], ["FDA-1975-N-0336-0018", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter", "Other", "Letter(s)", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2024-11-07T22:36:30Z", null, 1, 0, "0900006480f08ee0"], ["FDA-1975-N-0336-0012", "FDA", "FDA-1975-N-0336", "FDA/CDERLletter to Lemmon Co., DESI 597 - [ Teva Pharmaceuticals Co.] - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2024-11-12T05:02:18Z", null, 1, 0, "0900006480f076b7"], ["FDA-1975-N-0336-0006", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Carter-Wallace, Inc., DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2011-08-30T19:33:06Z", null, 0, 0, "0900006480f07671"], ["FDA-1975-N-0336-0007", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Ferdale Pharma Group, Inc - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2011-08-30T19:33:22Z", null, 0, 0, "0900006480f07678"], ["FDA-1975-N-0336-0013", "FDA", "FDA-1975-N-0336", "FDA/CDER letter to McNeil Pharmaceuticals., DESI 597 - [ Ortho-McNeil-Janssen Pharmaceuticals Inc.] - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2011-08-30T19:37:33Z", null, 0, 0, "0900006480f076ba"], ["FDA-1975-N-0336-0009", "FDA", "FDA-1975-N-0336", "FDA/CDER letter to Halsey Drug Co. - [ Acura Pharmaceuticals Co.] - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2024-11-07T22:36:38Z", null, 1, 0, "0900006480f076a0"], ["FDA-1975-N-0336-0011", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Lemmon Co., DESI 597 - [ Teva Pharmaceuticals Co.] - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2024-11-07T22:36:30Z", null, 1, 0, "0900006480f076b2"], ["FDA-1975-N-0336-0008", "FDA", "FDA-1975-N-0336", "FDA/CDER Letter to Halsey Drug Co., DESI 597 - [ Acura Pharmaceuticals Co.] - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2011-08-30T19:33:37Z", null, 0, 0, "0900006480f0767c"], ["FDA-1975-N-0336-0010", "FDA", "FDA-1975-N-0336", "FDA/CDER letter to Kremers-Urban Co. DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter", "Other", "Letter(s)", "2011-08-29T04:00:00Z", 2011, 8, "2011-08-29T04:00:00Z", null, "2024-11-07T22:36:30Z", null, 1, 0, "0900006480f076a2"], ["FDA-1975-N-0336-0005", "FDA", "FDA-1975-N-0336", "Letter from FDA CDER to Kleindeld, Kaplan & Becker LLP", "Other", "Letter(s)", "2011-08-25T04:00:00Z", 2011, 8, "2011-08-25T04:00:00Z", null, "2017-11-13T18:35:08Z", null, 0, 0, "0900006480eeb8ed"], ["FDA-1975-N-0336-0004", "FDA", "FDA-1975-N-0336", "Request for Hearing with Supporting Information Regarding Proposed Withdrawal of Approved Applications for Anticholinergic and Barbiturate Combination Drug Products (Buchanan Ingersoll & Rooney PC) (Vol 141-A)", "Other", "Request for Hearing", "2011-08-11T04:00:00Z", 2011, 8, "2011-08-11T04:00:00Z", null, "2017-12-05T21:41:21Z", null, 0, 0, "0900006480ec1a8d"], ["FDA-1975-N-0336-0003", "FDA", "FDA-1975-N-0336", "FDA/OC to PMB Pharmaceuticals, Inc.(Buchanan Ingersoll & Rooney, PC) - Letter", "Other", "Letter(s)", "2011-08-09T04:00:00Z", 2011, 8, "2011-08-09T04:00:00Z", null, "2011-08-09T19:57:46Z", null, 0, 0, "0900006480edc698"], ["FDA-1975-N-0336-0001", "FDA", "FDA-1975-N-0336", "Letter from West-Ward Pharmaceutical Corporation and PBM Pharmaceutical, Inc. to FDA/CDER", "Other", "Letter(s)", "2011-07-14T04:00:00Z", 2011, 7, "2011-07-14T04:00:00Z", null, "2017-12-06T15:37:11Z", null, 0, 0, "0900006480ebd5c8"], ["FDA-1975-N-0336-0002", "FDA", "FDA-1975-N-0336", "Letter from PBM Pharmaceutical, Inc. (Buchanan Ingersoll and Rooney, PC) to FDA", "Other", "Letter(s)", "2011-07-14T04:00:00Z", 2011, 7, "2011-07-14T04:00:00Z", null, "2017-12-06T15:54:22Z", null, 0, 0, "0900006480ebd5ca"]], "truncated": false, "filtered_table_rows_count": 31, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-1975-N-0336", "p2": "2011"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011", "results": [{"value": "FDA", "label": "FDA", "count": 31, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-1975-N-0336&posted_year=2011", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011", "results": [{"value": "Other", "label": "Other", "count": 31, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011", "results": [{"value": 2011, "label": 2011, "count": 31, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet=title"}, {"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet=last_modified"}, {"name": "open_for_comment", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1975-N-0336&posted_year=2011&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 444.5340660167858, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}